Find therapies in clinical trials near you – page 54

Study on the Safety and Effects of MBF-118 for Crohn's Disease Patients with Stenosis

Study on the Safety and Effects of MBF-118 for Crohn's Disease Patients with Stenosis

Study of Pembrolizumab and Cisplatin for Patients with Stage III-IVA Resectable Head and Neck Cancer

Study of Pembrolizumab and Cisplatin for Patients with Stage III-IVA Resectable Head and Neck Cancer

Study on Metreleptin for Patients with Partial Lipodystrophy

Study on Metreleptin for Patients with Partial Lipodystrophy

Study of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer

Study of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer

Study on Colchicine for Patients with Acute Heart Failure

Study on Colchicine for Patients with Acute Heart Failure

Study Comparing Subcutaneous Pembrolizumab with Hyaluronidase to Intravenous Pembrolizumab and Chemotherapy for First-line Treatment of Metastatic Non-Small Cell Lung Cancer

Study Comparing Subcutaneous Pembrolizumab with Hyaluronidase to Intravenous Pembrolizumab and Chemotherapy for First-line Treatment of Metastatic Non-Small Cell Lung Cancer

Study of Nivolumab and Ipilimumab for Patients with Stage 3 Non-Small Cell Lung Cancer Not Suitable for Surgery

Study of Nivolumab and Ipilimumab for Patients with Stage 3 Non-Small Cell Lung Cancer Not Suitable for Surgery

Study on Stopping Medication in Heart Failure Patients with Cardiac Resynchronization Therapy Using Eplerenone, Valsartan, and Bisoprolol Fumarate

Study on Stopping Medication in Heart Failure Patients with Cardiac Resynchronization Therapy Using Eplerenone, Valsartan, and Bisoprolol Fumarate

Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Study on the Effects of Atacicept in Adults with IgA Nephropathy

Study on the Effectiveness and Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Study on the Effectiveness and Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Study of Capivasertib with CDK4/6 Inhibitors and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer

Study of Capivasertib with CDK4/6 Inhibitors and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer